Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTasci, Elif Senocak
dc.contributor.authorOyan, Basak
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorMutlu, Arda Ulas
dc.contributor.authorAtci, Muhammed Mustafa
dc.contributor.authorOner, Irem
dc.contributor.authorCinkir, Havva Yesil
dc.contributor.authorEryilmaz, Melek Karakurt
dc.contributor.authorBalcik, Onur Yazdan
dc.contributor.authorPaksoy, Nail
dc.contributor.authorSalim, Derya Kivrak
dc.contributor.authorOzen, Mirac
dc.contributor.authorOzcelik, Melike
dc.contributor.authorArican, Ali
dc.contributor.authorInal, Ali
dc.contributor.authorAkagunduz, Baran
dc.contributor.authorAydin, Dincer
dc.contributor.authorOzer, Leyla
dc.contributor.authorTurhal, Nazim Serdar
dc.contributor.authorGulmez, Ahmet
dc.date.accessioned2025-10-16T15:17:51Z
dc.date.issued2022
dc.description.abstractASCO Gastrointestinal Cancers Symposium, San Francisco, CA, JAN 20-22, 2022
dc.identifier.doi10.1200/JCO.2022.40.4\_suppl.202
dc.identifier.otherWOS:000770995900198
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7025
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleEfficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS